Gov. Gavin Newsom said Thursday that California will begin selling affordable insulin under its own label on Jan. 1, nearly three years after he first announced a partnership to sell state-branded generic drugs at lower prices.

But California won’t be the only state making lower-cost insulin available. The nonprofit Civica said it will also distribute its economical diabetes medication to pharmacies nationwide. California began partnering with Civica in 2023 for its “CalRx” brand of insulin and put $50 million toward its development, the company said.

Starting in the new year, insulin pens will be available at a recommended price of $11 per pen, or a maximum of $55 for a five-pack, Civica said.

  • 草泥馬@mander.xyz
    cake
    link
    fedilink
    English
    arrow-up
    6
    ·
    edit-2
    2 days ago

    Can you imagine going broke paying for a life-saving drug knowing that elsewhere in your planet, the law dictates that people can get it for cheap?

    • ch00f@lemmy.world
      link
      fedilink
      arrow-up
      3
      ·
      2 days ago

      I mean the difference here is that you can there’s no immigration paperwork necessary to move states. You just drive/bus/walk.